LINK Medical is pleased to announce that we have been engaged by OncoZenge AB (publ) to conduct a feasibility study in preparation for the company’s planned European Phase III clinical trial of BupiZenge™.
The feasibility study will evaluate the availability and suitability of high-quality clinical trial sites across Germany, Denmark, Norway, and Sweden—regions well known for their robust clinical trial infrastructure and efficient regulatory processes. In addition to mapping site availability, the study will generate critical data on recruitment potential, including projected enrollment rates and site capacity. These insights will enable OncoZenge to de-risk its trial timeline and enhance operational preparedness.
“We’re excited to collaborate with OncoZenge on this important feasibility study. At LINK Medical, we specialize in guiding Nordic biotech companies through the complexities of the European clinical landscape. This partnership underscores our commitment to delivering hands-on expertise, local insights, and seamless execution to support our clients’ success at every stage of development."
— Anders Göransson, CEO, LINK Medical
This collaboration builds on LINK Medical’s strong regional presence and proven experience in supporting cross-border clinical trials throughout Northern Europe. Our team is dedicated to delivering high-quality feasibility insights to ensure the successful planning and execution of OncoZenge’s Phase III program.
We look forward to supporting OncoZenge on their journey toward delivering a much-needed, opioid-sparing solution for patients suffering from oral mucositis, and contributing to the success of this important treatment development.
About LINK Medical
LINK Medical is a Nordic-based, full-service CRO and regulatory partner supporting pharmaceutical and medical device companies across Northern Europe. With a broad range of expertise and one of the largest regulatory teams in the region, we offer flexible, high-quality services from early development to post-marketing. Founded in Oslo in 1995, LINK Medical combines local insight, scientific excellence, and a collaborative approach to drive successful product development.
